Before revision:  SUM149 /TIME platformswere 1.3 fold lower (p<0.05) , and MDA-MB-231 /TIME platforms were 1.5 fold lower (p< 0.01) in endothelial coverage compared to the control TIME only platform.
After revision:  SUM149 /TIME platformswere 1.3 fold lower (p<0.05) and increased collagen ECM porosity compared to non-IBC MDA-MB-231 /TIME platforms were 1.5 fold lower (p< 0.01) in endothelial coverage compared to the control TIME only platform.